Literature DB >> 581160

Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.

L Jokipii, P Karma, A M Jokipii.   

Abstract

Strictly anaerobic bacteria were found in about one third of 138 consecutive cases of active chronic otitis media. These infections were always mixed involving aerobes as well. In 79 cases only aerobes were found and 16 cultures were sterile. To provide a basis for possible clinical trials, the penetration of metronidazole into the ear was studied after an oral dose of 2.4 g to patients with chronic otitis media. Significant amounts of biologically active metronidazole were found in 8 of 12 middle ear discharges at 2--4 h, the concentrations varying between 9.4 and 65.0 microgram/ml. Between 2 and 13 h after administration, significant drug concentrations all exceeding the highest reported bactericidal ones were found in the middle ear mucosa in 6 cases of the 8 in which the determinations were possible. Neither the mucosal nor the discharge concentrations correlated with the simultaneous serum levels of metronidazole, which were high in all 23 patients studied.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581160     DOI: 10.1007/bf00457484

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  30 in total

1.  Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.

Authors:  H R Ingham; G E Rich; J B Selkon; J H Hale; C M Roxby; M J Betty; R W Johnson; P R Uldall
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

2.  An investigation of interactions between metronidazole ("Flagl") and other antibacterial agents.

Authors:  A R Salem; D D Jackson; J A McFadzean
Journal:  J Antimicrob Chemother       Date:  1975-12       Impact factor: 5.790

3.  ABSORPTION, DIFFUSION, AND EXCRETION OF A NEW ANTIBIOTIC, LINCOMYCIN.

Authors:  A MEDINA; N FISKE; I HJELT-HARVEY; C D BROWN; A PRIGOT
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

4.  Specific inhibition of obligate anaerobes.

Authors:  H N PRINCE
Journal:  Nature       Date:  1960-06-04       Impact factor: 49.962

5.  Penetration of the blood brain barrier by metronidazole and tinidazole.

Authors:  A M Jokipii; V V Myllylä; E Hokkanen; L Jokipii
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

6.  Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole.

Authors:  R H George; A J Bint
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

7.  [Biological method of metronidazole and dimetridazole determination on anaerobic germs].

Authors:  D Videau
Journal:  Pathol Biol (Paris)       Date:  1972 Jun-Jul

8.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

9.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

10.  Metronidazole in prevention and treatment of bacteroides infections after appendicectomy.

Authors:  A T Willis; I R Ferguson; P H Jones; K D Phillips; P V Tearle; R B Berry; R V Fiddian; D F Graham; D H Harland; D B Innes; W M Mee; R L Rothwell-Jackson; I Sutch; C Kilbey; D Edwards
Journal:  Br Med J       Date:  1976-02-07
View more
  3 in total

Review 1.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Metronidazole bioassay with increased sensitivity.

Authors:  L Jokipii; A M Jokipii
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

3.  Metronidazole uptake in the cholesteatomatous membrane in chronic otitis media.

Authors:  S Kristensen; A Juul; A Rosetzsky
Journal:  Arch Otorhinolaryngol       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.